# US 2008/0188748 A1 · Methods of prenatal screening for trisomy 21

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0188748 A1
- Document ID: US20080188748A1
- Status: Published application
- Kind: A1
- Application number: 11/888,554
- Filed: 2007-08-01
- Published: 2008-08-07
- Earliest claimed: 2006-08-01
- Inventors: Jiri D. Sonek; Kypros H. Nicolaides
- Web page: https://patentgrep.com/patent/US20080188748A1

## CPC

- A61B 8/0866: {involving foetal diagnosis; pre-natal or peri-natal diagnosis of the baby}
- A61B 5/1075: {for measuring dimensions by non-invasive methods, e.g. for determining thickness of tissue layer (A61B8/0858 takes precedence)}
- A61B 8/483: {involving the acquisition of a 3D volume of data}
- A61B 5/4504: {Bones (A61B5/4547 takes precedence)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Methods for prenatal screening for trisomy 21 employ examination of the fronto-maxillary facial (FMF) angle of a fetus. In one embodiment, the methods comprise obtaining a two or three dimensional image of a fetal face, measuring the FMFbone angle on the image, and comparing the measured FMFbone angle with an FMFbone angle characteristic of chromosomally normal fetuses, wherein a measured FMFbone angle greater than the FMFbone angle characteristic of chromosomally normal fetuses provides an indication of an increased likelihood of the occurrence of trisomy 21 in the fetus. In another embodiment, the methods comprise obtaining a two or three dimensional image of a fetal face, measuring the FMFskin angle on the image, and comparing the measured FMFskin angle with an FMFskin angle characteristic of chromosomally normal fetuses, wherein a measured FMFskin angle greater than the FMFskin angle characteristic of chromosomally normal fetuses provides an indication of an increased likelihood of the occurrence of trisomy 21 in the fetus. In additional embodiments, both FMFbone angle and FMFskin angle are measured and compared with values characteristic of chromosomally normal fetuses.

## Claims

### Claim 1

A method for prenatal screening for trisomy 21, comprising obtaining a two or three dimensional image of a fetal face, measuring the angle between a line extending along the upper aspect of the maxilla and a line extending from the anterior aspect of the maxilla to the external surface of the frontal bone at the point of its greatest anterior excursion (the FMFbone angle) on the image, and comparing the measured FMFbone angle with an FMFbone angle characteristic of chromosomally normal fetuses, wherein a measured FMFbone angle greater than the FMFbone angle characteristic of chromosomally normal fetuses provides an indication of an increased likelihood of the occurrence of trisomy 21 in the fetus.

### Claim 2 (depends on 1)

The method of claim 1, wherein the image of the fetal face is obtained through three dimensional ultrasound.

### Claim 3 (depends on 2)

The method of claim 2, wherein the image comprises a mid-sagittal view of the fetal face.

### Claim 4 (depends on 1)

The method of claim 1, wherein the image is obtained from a fetus at 10 or greater weeks of gestation.

### Claim 5 (depends on 1)

The method of claim 1, wherein the image is obtained from a fetus at 10-19 weeks of gestation.

### Claim 6 (depends on 1)

The method of claim 1, wherein the image is obtained from a fetus at 10-13 weeks of gestation.

### Claim 7 (depends on 1)

The method of claim 1, wherein the image is obtained from a fetus at 14-23 weeks of gestation.

### Claim 8 (depends on 1)

The method of claim 1, wherein the measured FMFbone angle is greater than 80°.

### Claim 9 (depends on 1)

The method of claim 1, wherein the measured FMFbone angle is greater than 90°.

### Claim 10 (depends on 1)

The method of claim 1, wherein the FMFbone angle is the angle between a line extending along the upper aspect of the maxilla and the vomer bone and a line extending from the anterior aspect of the maxilla to the external surface of the frontal bone at the point of its greatest anterior excursion.

### Claim 11

A method for prenatal screening for trisomy 21 in a fetus at 14-23 weeks of gestation, comprising obtaining a two or three dimensional image of a fetal face, measuring the angle between a line extending along the upper aspect of the maxilla and a line extending from the anterior aspect of the maxilla to the external skin surface along the frontal bone at the point of its greatest anterior excursion (the FMFskin angle) on the image, and comparing the measured FMFskin angle with an FMFskin angle characteristic of chromosomally normal fetuses, wherein a measured FMFskin angle greater than the FMFskin angle characteristic of chromosomally normal fetuses provides an indication of a likelihood of the occurrence of trisomy 21 in the fetus.

### Claim 12 (depends on 11)

The method of claim 11, wherein the image of a fetal face is obtained through three dimensional ultrasound.

### Claim 13 (depends on 12)

The method of claim 12, wherein the image comprises a mid-sagittal view of the fetal face.

### Claim 14 (depends on 11)

The method of claim 11, wherein the measured FMFskin angle is greater than 80°.

### Claim 15 (depends on 11)

The method of claim 11, wherein the measured FMFskin angle is greater than 85°.

### Claim 16 (depends on 11)

The method of claim 11, wherein the FMFskin angle is the angle between a line extending along the upper aspect of the maxilla and the vomer bone and a line extending from the anterior aspect of the maxilla to the external skin surface along the frontal bone at the point of its greatest anterior excursion.

### Claim 17 (depends on 11)

The method of claim 11, further comprising measuring the angle between a line extending along the upper aspect of the maxilla and a line extending from the anterior aspect of the maxilla to the external surface of the frontal bone at the point of its greatest anterior excursion (the FMFbone angle) on a two or three dimensional image obtained from the fetus, and comparing the measured FMFbone angle with an FMFbone angle characteristic of chromosomally normal fetuses, wherein a measured FMFbone angle greater than the FMFbone angle characteristic of chromosomally normal fetuses provides a further indication of a likelihood of the occurrence of trisomy 21 in the fetus.

### Claim 18 (depends on 17)

The method of claim 17, wherein the FMFbone angle is measured from an image obtained from the fetus at 10-13 weeks of gestation.

### Claim 19 (depends on 18)

The method of claim 18, wherein the FMFbone angle is measured from an image obtained through three dimensional ultrasound.
